comparemela.com

Latest Breaking News On - Curium inc - Page 1 : comparemela.com

Curasight announces acceleration of therapeutic strategy to strengthen position as a radiopharmaceutical theranostic company

/PRNewswire/ Curasight A/S ("Curasight" or the "Company" (XSAT: CURAS) announces today that it is accelerating and expanding its clinical therapeutic.

Curasight A/S Achieves First Milestone under collaboration with Curium Inc

USD 500.000 payment is the first milestone under the global license and collaboration agreement for the development and commercialization of uTRACE® for use in.

Curasight: Interim report Q1 2023

Curasight: Interim report Q1 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Curasight: Interim report Q1 2023 | MarketScreener

COPENHAGEN, Denmark, May 25, 2023 /PRNewswire/  Curasight A/S hereby publishes the interim report Q1 2023. The interim report is available as an attached file to this release and on the. | May 25, 2023

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.